FindTrial
Sign In

Puudutteet tinnituksen hoidossa- ropivakaiinin ja lidokaiinin vertailu

Puudutteet tinnituksen hoidossa- ropivakaiinin ja lidokaiinin vertailu

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-003098-28-FI
Enrollment
Unknown
Registered
2006-06-05
Start date
2006-05-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus MedDRA version: 8.1 Level: LLT Classification code 10043882 Term: Tinnitus

Interventions

Trade Name: Naropin Pharmaceutical Form: Injection* INN or Proposed INN: ROPIVACAINE HYDROCHLORIDE Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 10-

Sponsors

HUS, Korvaklinikka
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026